PRE1BRAZIL Protocol: A Randomized Controlled Trial to Evaluate the Effectiveness and Safety of the DPP-4 Inhibitor Alogliptin in Delaying the Progression of Stage 2 Type 1 Diabetes

Penaforte-Saboia JG, Couri CEB, Albuquerque NV, Lindard LLP, Araújo DAC, Oliveira SKP, Gomes TFP, Pinheiro MM, Castelo MHCG, Fernandes VO, Montenegro Júnior RM

Diabetes, Metabolic Syndrome and Obesity 2024, 17:857-864

Published Date: 21 February 2024